Lucas P. Carvalho
Conselho, BA, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 82 publications
Rapid phagosome formation drives parasite control in subclinical Leishmania braziliensis infection.
Journal: Frontiers in immunology
Published: March 23, 2026
Annexin A1 downregulates in vitro IL-1β production in L. braziliensis-infected cells.
Journal: Frontiers in immunology
Published: August 13, 2025
Spatial profiling of human diffuse cutaneous leishmaniasis lesions reveals immunosuppressive microenvironments that coincide with parasite localization.
Journal: The Journal of investigative dermatology
Published: July 16, 2025
High glucose heightens vulnerability to Leishmania braziliensis infection in human macrophages by hampering the production of reactive oxygen species through TLR2 and TLR4.
Journal: Emerging microbes & infections
Published: March 07, 2025
A Quantitative Polymerase Chain Reaction (qPCR) Protocol Predictive of Treatment Outcome in Cutaneous Leishmaniasis Caused by Leishmania braziliensis.
Journal: Open forum infectious diseases
Published: December 09, 2024
Topical AuNPs-Cys-Sm29 gel modulates the course of lesion development in experimental cutaneous leishmaniasis.
Journal: PLoS neglected tropical diseases
Published: October 27, 2024
The Leishmania Skin Test Predicts Clinic-Immunologic and Therapeutic Outcomes in Cutaneous Leishmaniasis.
Journal: Pathogens (Basel, Switzerland)
Published: October 11, 2024
ATP-binding cassette transporters and drug resistance in cutaneous leishmaniasis.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: August 09, 2024
Lack of Hypoxia Inducible Factor-1α Influences on Macrophages Ability to Deal with Leishmania braziliensis In Vitro and Affects Pathology In Vivo.
Journal: JID innovations : skin science from molecules to population health
Published: June 12, 2024
Use of topical rSm29 in combination with intravenous meglumine antimoniate in the treatment of cutaneous leishmaniasis: A randomized controlled trial.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: March 25, 2024
Last Updated: 09/26/2026